T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFPT
326
DELISTED
Proofpoint, Inc.
PFPT
| $372M | 0.06% |
4,184,997
-1,206,908
| -22% | -$110M |
|
327
Lennar Class A
LEN
$21.1B
| $369M | 0.06% |
6,026,839
+1,622,160
| +37% | +$92.2M |
|
328
Starbucks
SBUX
$122B
| $365M | 0.06% |
6,347,171
-1,214,873
| -16% | -$68.8M |
|
329
Wabtec
WAB
$50.3B
| $363M | 0.06% |
4,462,971
-154,672
| -3% | -$11.8M |
|
|
MAXR
330
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $359M | 0.06% |
+5,580,079
| New | +$353M |
|
331
Acadia Healthcare
ACHC
$2.9B
| $358M | 0.06% |
10,963,687
-79,838
| -0.7% | -$2.77M |
|
332
Edison International
EIX
$26.9B
| $355M | 0.06% |
5,615,500
-2,187,699
| -28% | -$167M |
|
333
Essex Property Trust
ESS
$18.2B
| $354M | 0.06% |
1,465,734
-158,009
| -10% | -$39.9M |
|
334
Watsco Inc
WSO
$13.2B
| $352M | 0.06% |
2,072,770
+240,349
| +13% | +$39.7M |
|
335
Diamondback Energy
FANG
$56.5B
| $352M | 0.06% |
2,789,224
-83,496
| -3% | -$9.05M |
|
336
Toro Company
TTC
$9.41B
| $352M | 0.06% |
5,390,980
-53,324
| -1% | -$3.38M |
|
337
Analog Devices
ADI
$188B
| $352M | 0.06% |
3,948,589
-347,718
| -8% | -$30.8M |
|
338
Bankunited
BKU
$3.35B
| $350M | 0.06% |
8,603,839
+26,549
| +0.3% | +$966K |
|
339
Altria Group
MO
$109B
| $349M | 0.06% |
4,888,513
-358,952
| -7% | -$24.1M |
|
|
SIVB
340
DELISTED
SVB Financial Group
SIVB
| $344M | 0.06% |
1,469,463
-288,255
| -16% | -$61.4M |
|
|
SEM
341
DELISTED
Select Medical
SEM
| $343M | 0.06% |
36,037,273
+179,080
| +0.5% | +$1.71M |
|
|
SBNY
342
DELISTED
Signature Bank
SBNY
| $337M | 0.05% |
2,451,593
-11,193
| -0.5% | -$1.47M |
|
343
ONE Gas
OGS
$5B
| $335M | 0.05% |
4,571,352
-80,257
| -2% | -$6.08M |
|
344
Kroger
KR
$34.5B
| $335M | 0.05% |
12,199,190
+74,640
| +0.6% | +$1.74M |
|
345
Union Pacific
UNP
$174B
| $335M | 0.05% |
2,496,648
-44,281
| -2% | -$5.34M |
|
346
Pentair
PNR
$10.7B
| $329M | 0.05% |
6,930,705
-4,705,118
| -40% | -$220M |
|
347
Pricesmart
PSMT
$5.33B
| $328M | 0.05% |
3,813,511
-86,022
| -2% | -$7.34M |
|
348
Ulta Beauty
ULTA
$23.3B
| $328M | 0.05% |
1,464,972
+1,299,575
| +786% | +$275M |
|
|
MIK
349
DELISTED
Michaels Stores, Inc
MIK
| $326M | 0.05% |
13,482,347
-4,933,285
| -27% | -$102M |
|
350
Idexx Laboratories
IDXX
$46.2B
| $323M | 0.05% |
2,065,246
-234,421
| -10% | -$36.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.